pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,161 catalysts · 5,159 phase readout · 2,286 8k filing · 315 pdufa · 256 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 0 catalysts2026-07-30: 14 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 16 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: approval×type: grant×type: phase readout×clear all
type
  • phase readout5,159
  • 8k filing2,286
  • pdufa315
  • earnings256
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

11
›RECRUITINGphase readoutNCT06931340: Testing the Addition of Docetaxel (Chemotherapy) to the Usual Treatment (Hormonal Therapy and Apalutamide) for Metastatic Prostate Cancer, ASPIRE Trial

Sponsor: Alliance for Clinical Trials in Oncology. Phase: PHASE3. Conditions: Castration-Sensitive Prostate Carcinoma, Metastatic Prostate Adenocarcinoma, Stage IVB Prostate Cancer AJCC v8

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07667868: A Phase I, Open-label, Multicenter Study to Evaluate the Safety and Tolerability of BP2202 in Patients With Relapsed/Refractory Multiple Myeloma

Sponsor: BrightPath Biotherapeutics Co., Ltd.. Phase: PHASE1. Conditions: Relapsed/Refractory Multiple Myeloma (RRMM)

full page →ctgov ↗
›COMPLETEDphase readoutNCT07236268: Prevalence of HIV and Sexually Transmitted Infections in Migrant Communities in Slovakia

Sponsor: Comenius University. Phase: . Conditions: STIs, HIV, Rapid Detection

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05621850: Impact of CErebral Endovascular PROcedures on the Systemic Immune responSe Response

Sponsor: University Hospital, Limoges. Phase: NA. Conditions: Cerebral Arterio-venous Malformation

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07571291: DEVELOPMENT OF INNOVATIVE TARGETED LIPOSOMAL FORMULATIONS FOR THE TREATMENT OF INFLAMMATORY DRIVEN PULMONARY FIBROSIS

Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: Pulmonary Fibrosis

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06094491: Virtual Diabetes Group Visits Across Health Systems

Sponsor: University of Chicago. Phase: NA. Conditions: T2DM (Type 2 Diabetes Mellitus), Hypertension, Heart Disease Chronic, Stroke, Hyperlipidemias, Peripheral Vascular Diseases, Obesity

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07260760: Clinical Comprehensive Evaluation of Neuroprotective Drugs for Acute Ischemic Stroke

Sponsor: Qianfoshan Hospital. Phase: . Conditions: Acute Ischemic Stroke

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07493460: Longitudinal Tracking of Bone Marrow Plasma Cell Responses to Licensed Human Vaccines

Sponsor: Washington University School of Medicine. Phase: PHASE4. Conditions: Immunology, Healthy Adults

full page →ctgov ↗
›COMPLETEDphase readoutNCT04273360: Restrictive Use of Restraints and Delirium Duration in ICU

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Restraint, Physical, Mechanical Ventilation

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07414160: Association Between Dynamic Prealbumin Trajectories and Prognosis in Critically Ill Patients

Sponsor: The First Hospital of Jilin University. Phase: . Conditions: ICU, Critical Illness, Adult

full page →ctgov ↗
›RECRUITINGphase readoutNCT07588360: Haplo-Cord HSCT for AML/MDS

Sponsor: Fujian Medical University Union Hospital. Phase: NA. Conditions: MDS (Myelodysplastic Syndrome), AML (Acute Myeloid Leukemia)

full page →ctgov ↗
← prev
page 104 of 104
next →